Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial

0Tip RSCInsights

Authors

Francis Chan•Grace Wong16 more•Joseph Sung

Journal

The Lancet

Published

May 1, 2007

Supporters

Support the authors with ResearchCoin

Tip RSC

Topics

Pathology

Pharmacology

Medicine

Internal Medicine

Double Blind

Show all topics

DOI

10.1016/s0140-6736(07)60749-1

License

Unknown License